Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC6 | Q9UBN7 | 14/20 | 0.37 |
| ▸ | HDAC1 | Q13547 | 12/20 | 0.37 |
| ▸ | HDAC3 | O15379 | 10/20 | 0.37 |
| ▸ | HDAC2 | Q92769 | 10/20 | 0.37 |
| ▸ | HDAC10 | Q969S8 | 10/20 | 0.37 |
| ▸ | HDAC11 | Q96DB2 | 10/20 | 0.37 |
| ▸ | HDAC8 | Q9BY41 | 10/20 | 0.37 |
| ▸ | HDAC4 | P56524 | 8/20 | 0.37 |
| ▸ | HDAC7 | Q8WUI4 | 8/20 | 0.37 |
| ▸ | HDAC9 | Q9UKV0 | 8/20 | 0.37 |
| ▸ | HDAC5 | Q9UQL6 | 8/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | NCOR2 | Q9Y618 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7164859 | 1.00 | HDAC6 (0.37) | HDAC6HDAC1HDAC3HDAC2HDAC10 | |
| SCHEMBL7167752 | 0.92 | KDM4E (0.41) | HDAC6HDAC1HDAC3HDAC2HDAC10 | |
| SCHEMBL7162529 | 0.89 | KDM4E (0.36) | KDM4EMAPTATML3MBTL1 | |
| SCHEMBL7165195 | 0.86 | KDM4E (0.34) | HDAC6HDAC1HDAC3HDAC2HDAC10 | |
| SCHEMBL7168541 | 0.84 | HDAC3 (0.40) | HDAC6HDAC1HDAC3HDAC2HDAC8 | |
| SCHEMBL7193348 | 0.80 | HDAC1 (0.44) | HDAC6HDAC1HDAC3HDAC2HDAC10 | |
| SCHEMBL7169367 | 0.75 | SMN1; SMN2 (0.41) | HDAC6HDAC1HDAC3HDAC2HDAC10 | |
| SCHEMBL7164949 | 0.68 | KDM4E (0.42) | KDM4EMAPTATML3MBTL1 | |
| SCHEMBL7185400 | 0.67 | L3MBTL1 (0.40) | HDAC6HDAC1HDAC3HDAC2HDAC10 | |
| SCHEMBL7167694 | 0.67 | HDAC1 (0.42) | HDAC6HDAC1HDAC3HDAC2HDAC10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6531472-B2 | Has histone deacetylase (HDAC) inhibitory activity which is useful in cancer treatment | HOFFMAN-LA ROCHE INC. | 2003-03-11 | — | — | US | claimed |
| US-20020065282-A1 | Tetralone derivatives | F. HOFFMANN-LA ROCHE AG (CH) | 2002-05-30 | — | — | US | claimed |
| US-6531472-B2 | Has histone deacetylase (HDAC) inhibitory activity which is useful in cancer treatment | HOFFMAN-LA ROCHE INC. | 2003-03-11 | — | — | US | disclosed |
| US-20020065282-A1 | Tetralone derivatives | F. HOFFMANN-LA ROCHE AG (CH) | 2002-05-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020065282-A1 | Tetralone derivatives | HDAC1, HDAC5, HDAC3 | HDAC6 11/4885HDAC1 1/4885HDAC3 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.